Shasqi

Targeting cancer with click chemistry

San Francisco, United States · Founded 2015 · $65.5M raised

Employees
11–50
Founded
2015
Business Model
B2B
Website
shasqi.com
Total Funding
$65.5M
Last Round
$2.1M GrantAug 2024
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Shasqi is a clinical-stage biotech using Nobel Prize-winning click chemistry to develop tumor-targeted cancer therapies. Its CAPAC platform uses pre-targeting to activate drugs selectively at the tumor, enabling higher doses with reduced systemic toxicity. The company has collaborations with Johnson & Johnson and NIH, and is advancing its lead asset SQ3370 through clinical trials.

Summary

Shasqi is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $65.5M in total across 8 rounds, most recently a $2.1M Grant round in Aug 2024. Investors include Y Combinator, Juan Jaen and Bill Rieflin.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Aug 2024
$2.1M

Sign up to see all 8 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Shasqi on Indexed.vc
<a href="https://indexed.vc/companies/shasqi-inc-"><img src="https://indexed.vc/api/badge/company/shasqi-inc-" alt="Shasqi on Indexed.vc" width="260" height="76" /></a>